99.
[1]. F S Steven, et al. Evidence for an enzyme which cleaves the guanidinobenzoate moiety from active-site titrants specifically designed to inhibit and quantify trypsin. Eur J Biochem. 1983 Feb 1;130():335-9.
[]. G T Layton, et al. The specificity of murine polyclonal and monoclonal antibodies to the haptenic drug chlorhexidine induced by chlorine-generated chlorhexidine-protein conjugates. Clin Exp Immunol. 1987 Jul;69(1):157-65.
[3]. H J Nolte, et al. Kinetics and mechanism for the conformational transition in p-guanidinobenzoate bovine trypsinogen induced by the isoleucine-valine dipeptide. Biophys Chem. 1979 Nov;10(3-):53-60.
[]. K Beckh, et al. Elimination of the low-molecular weight proteinase inhibitor camostate (FOY 305) and its degradation products by the rat liver. Res Exp Med (Berl). 1987;187(6):01-6.
[5]. K Beckh, et al. Hepatic and pancreatic metabolism and biliary excretion of the protease inhibitor camostat mesilate. Int J Pancreatol. 1991 Nov-Dec;10(3-):197-05.
H30-H315-H319-H335
P61-P6-P70-P71-P80-P30+P35-P30+P30-P305+P351+P338-P330-P36+P36-P03+P33-P05-P501